Pulmonary hypertension and right heart failure in COPD

Monaldi Archives for Chest Disease

Volumn 59, Issue 3, 2003, Pages 250-253

  Naeije, Robert ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ENDOTHELIN RECEPTOR ANTAGONIST; NITRIC OXIDE; OXYGEN; PROSTACYCLIN DERIVATIVE; VASODILATOR AGENT;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TEST; HEART ATRIUM PRESSURE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE OVERLOAD; HUMAN; LUNG BLOOD FLOW; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; OXYGEN THERAPY; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; SODIUM RETENTION; WATER RETENTION; CONFERENCE PAPER; LUNG ARTERY PRESSURE;

EID: 1642484968     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Wilkinson M, Langhorn CA, Heath D, Barer GR, Howard P. A pathophysiological study of 10 cases of hypoxic cor pulmonale. Q J Med 1988; 66: 65-85.
2. Peinado VI, Barbera JA, Abate P, Ramirez J, Roca J, Santos S, Rodriguez-Roisin R. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 59: 1605-1611
3. Heath D, Williams DR. High-altitude medicine and pathology. Butterworths, London, 1989; chap 10, pp 102-114.
4. Lejeune P, Mols P, Naeije R, Hallemans R, Mélot C. Acute hemodynamic effects of controlled oxygen therapy in decompensated chronic obstructive pulmonary disease. Crit Care Med 1984; 12: 1032-1035.
5. Timms RM, Khaja FU, Williams GW, and the Nocturnal Oxygen Therapy Trial Group. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med 1985; 102: 29-36.
6. Naeije R, McNee W. Pulmonary hemodynamics in COPD. In: PMA Calverley, McNee W, Pride NB and Rennard SI (eds) Chronic Obstructive Pulmonary Disease, second edition, Arnold, London, 2003, pp 228-242.
7. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1977; 336: 111-117.
8. Naeije R. Cor pulmonale. In: Pulmonary Diseases. C Grassi, C Brambilla, RA Stockley, R Naeije, R Rodriguez-Roisin, and AP Fishmaneditors. McGraw-Hill Clinical Medicine Series. McGraw-Hill International (UK) Ltd, London, 1999, pp 355-364.
9. Harris P, Segel N, Bishop JM. The relation between pressure and flow in the pulmonary circulation in normal subjects and in patients with chronic bronchitis and mitral stenosis. Cardiovasc Res 1968; 2: 73-83.
10. McGregor M, Sniderman A. On pulmonary vascular resistance: the need for more precise definition. Am J Cardiol 1985; 55: 217-221.
11. Vizza CD, Rocca GD, Roma AD, Iacoboni C, Pierconti F, Venuta F, Rendina E, Schmid G, Pietropaoli P, Fedele F. Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. Crit Care 2001; 5: 355-361.
12. Lejeune P, Naeije R, Leeman M, Mélot C, Deloof T, Delcroix M. Effects of dopamine and dobutamine on hyperoxic and hypoxic pulmonary vascular tone in dogs. Am Rev Respir Dis 1987; 136: 29-37.
13. Grunig E, Janssen B, Mereles D, Barth U, Borst MM, Vogt IR, Fischer C, Olschewski H, Kuecherer HF, Kubler W. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation 2000; 102: 1145-1150.
14. Riley RL, Himmelstein A, Morley HL, Motley HL, Weiner HM, Cournand A. Studies on the pulmonary circulation at rest and during exercise in normal individuals and in patients with chronic pulmonary disease. Am J Physiol 1948; 152; 372-382.
15. Kessler R, Faller M, Weitzenblum E, Chaouat A, Aykut A, Ducolone A,OEhrhart M, Oswald-Mammosser M. "NAtural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164: 219-224.
16. Agustí AGN, Barberà JA, Roca J, Wagner PD, Guitart R, Rodriguez-Roisin R. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. Chest 1990; 97: 268-275.
17. Bauduin SV. Oedema and cor pulmonale revisited. Thorax 1997; 52: 401-402.
18. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 833-852 and 1158-1168.
19. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR, Wells FC, Wallwork J. Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease. N Engl J Med 1991; 324: 1539-1547.
20. Peinado VI, Barberà JA, Ramirez J, Gomez FP, Roca J, Jover L, Gimferrer JM, Rodriguez-Roisin R. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol 1998; 274: L908-L913.
21. Barbera JA, Peinado VI, Santos S, Ramirez J, Roca J, Rodriguez-Roisin R. Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. Am J Respir Crit Care Med 2001; 164: 709-713.
22. Galié N, Manes A, Branzi A. Medical therapy of pulmonary hypertension: The prostacyclins. Clin Chest Med 2001; 22: 529-537.
23. Rubin LJ, Badesch DR, Barst RJ, Galié N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346: 896-903.
24. Wasserman K. Diagnosing cardiovascular and lung pathophysiology from exercise gas exchange. Chest 1997; 112: 1091-1101.